Structural dynamics of the active HER4 and HER2/HER4 complexes is finely tuned by different growth factors and glycosylation
Human Epidermal growth factor Receptor 4 (HER4 or ERBB4) carries out essential functions in the development and maintenance of the cardiovascular and nervous systems. HER4 activation is regulated by a diverse group of extracellular ligands including the neuregulin (NRG) family and betacellulin (BTC)...
Main Authors: | Raphael Trenker, Devan Diwanji, Tanner Bingham, Kliment A Verba, Natalia Jura |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2024-03-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/92873 |
Similar Items
-
HER3 in cancer: from the bench to the bedside
by: Lucía Gandullo-Sánchez, et al.
Published: (2022-10-01) -
Ebselen oxide and derivatives are new allosteric HER2 inhibitors for HER2‐positive cancers
by: Lucas Blasquez, et al.
Published: (2023-10-01) -
Targeting HER3 to overcome EGFR TKI resistance in NSCLC
by: Qiuqiang Chen, et al.
Published: (2024-01-01) -
Preclinical Characteristics of the Irreversible Pan-HER Kinase Inhibitor Neratinib Compared with Lapatinib: Implications for the Treatment of HER2-Positive and <i>HER2</i>-Mutated Breast Cancer
by: Denis M. Collins, et al.
Published: (2019-05-01) -
Prevention and Therapy of Metastatic HER-2<sup>+</sup> Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine
by: Francesca Ruzzi, et al.
Published: (2022-10-01)